Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Potential therapeutic applications of muscle-derived mesenchymal stem and progenitor cells.

Jackson WM, Nesti LJ, Tuan RS.

Expert Opin Biol Ther. 2010 Apr;10(4):505-17. doi: 10.1517/14712591003610606. Review.

2.

Stem cells from amniotic fluid--Potential for regenerative medicine.

Loukogeorgakis SP, De Coppi P.

Best Pract Res Clin Obstet Gynaecol. 2016 Feb;31:45-57. doi: 10.1016/j.bpobgyn.2015.08.009. Epub 2015 Sep 10. Review.

PMID:
26542929
3.

[Mesenchymal stem cells as a therapeutic tool in tissue and organ regeneration].

Bajek A, Olkowska J, Drewa T.

Postepy Hig Med Dosw (Online). 2011 Feb 24;65:124-32. Review. Polish.

4.

Differentiation potential of multipotent progenitor cells derived from war-traumatized muscle tissue.

Nesti LJ, Jackson WM, Shanti RM, Koehler SM, Aragon AB, Bailey JR, Sracic MK, Freedman BA, Giuliani JR, Tuan RS.

J Bone Joint Surg Am. 2008 Nov;90(11):2390-8. doi: 10.2106/JBJS.H.00049.

5.

Myogenic potential of mesenchymal stem cells - the case of adhesive fraction of human umbilical cord blood cells.

Grabowska I, Streminska W, Janczyk-Ilach K, Machaj EK, Pojda Z, Hoser G, Kawiak J, Moraczewski J, Ciemerych MA, Brzoska E.

Curr Stem Cell Res Ther. 2013 Jan;8(1):82-90.

PMID:
23270632
6.

Platelet-derived growth factor receptors regulate mesenchymal stem cell fate: implications for neovascularization.

Ball SG, Shuttleworth CA, Kielty CM.

Expert Opin Biol Ther. 2010 Jan;10(1):57-71. doi: 10.1517/14712590903379510. Review.

PMID:
20078229
7.

TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration.

Girgenrath M, Weng S, Kostek CA, Browning B, Wang M, Brown SA, Winkles JA, Michaelson JS, Allaire N, Schneider P, Scott ML, Hsu YM, Yagita H, Flavell RA, Miller JB, Burkly LC, Zheng TS.

EMBO J. 2006 Dec 13;25(24):5826-39. Epub 2006 Nov 23.

8.

Characterization and osteogenic potential of equine muscle tissue- and periosteal tissue-derived mesenchymal stem cells in comparison with bone marrow- and adipose tissue-derived mesenchymal stem cells.

Radtke CL, Nino-Fong R, Esparza Gonzalez BP, Stryhn H, McDuffee LA.

Am J Vet Res. 2013 May;74(5):790-800. doi: 10.2460/ajvr.74.5.790.

PMID:
23627394
9.

The endometrium as a source of mesenchymal stem cells for regenerative medicine.

Mutlu L, Hufnagel D, Taylor HS.

Biol Reprod. 2015 Jun;92(6):138. doi: 10.1095/biolreprod.114.126771. Epub 2015 Apr 22. Review.

10.

Immunological characteristics of human mesenchymal stem cells and multipotent adult progenitor cells.

Jacobs SA, Roobrouck VD, Verfaillie CM, Van Gool SW.

Immunol Cell Biol. 2013 Jan;91(1):32-9. doi: 10.1038/icb.2012.64. Review.

11.

Therapeutic application of mesenchymal stem cell-derived exosomes: A promising cell-free therapeutic strategy in regenerative medicine.

Motavaf M, Pakravan K, Babashah S, Malekvandfard F, Masoumi M, Sadeghizadeh M.

Cell Mol Biol (Noisy-le-grand). 2016 Jun 30;62(7):74-9. Review.

PMID:
27453276
12.

Pericytes, mesenchymal stem cells and their contributions to tissue repair.

Wong SP, Rowley JE, Redpath AN, Tilman JD, Fellous TG, Johnson JR.

Pharmacol Ther. 2015 Jul;151:107-20. doi: 10.1016/j.pharmthera.2015.03.006. Epub 2015 Mar 28. Review.

PMID:
25827580
13.

Ecto-mesenchymal stem cells from facial process: potential for muscle regeneration.

Nie X, Xing Y, Deng M, Gang L, Liu R, Zhang Y, Wen X.

Cell Biochem Biophys. 2014 Sep;70(1):615-22. doi: 10.1007/s12013-014-9964-x.

PMID:
24748180
14.

Regeneration of cartilage and bone by defined subsets of mesenchymal stromal cells--potential and pitfalls.

Aicher WK, Bühring HJ, Hart M, Rolauffs B, Badke A, Klein G.

Adv Drug Deliv Rev. 2011 Apr 30;63(4-5):342-51. doi: 10.1016/j.addr.2010.12.004. Epub 2010 Dec 22. Review.

PMID:
21184789
15.

Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration.

Nakamura Y, Miyaki S, Ishitobi H, Matsuyama S, Nakasa T, Kamei N, Akimoto T, Higashi Y, Ochi M.

FEBS Lett. 2015 May 8;589(11):1257-65. doi: 10.1016/j.febslet.2015.03.031. Epub 2015 Apr 8.

16.

The role of mesenchymal stromal cells in spinal cord injury, regenerative medicine and possible clinical applications.

Forostyak S, Jendelova P, Sykova E.

Biochimie. 2013 Dec;95(12):2257-70. doi: 10.1016/j.biochi.2013.08.004. Epub 2013 Aug 27. Review.

PMID:
23994163
17.

Fibrin glue as the cell-delivery vehicle for mesenchymal stromal cells in regenerative medicine.

Wu X, Ren J, Li J.

Cytotherapy. 2012 May;14(5):555-62. doi: 10.3109/14653249.2011.638914. Epub 2011 Dec 16. Review.

PMID:
22175911
18.

Human embryonic stem cell-derived mesoderm-like epithelium transitions to mesenchymal progenitor cells.

Boyd NL, Robbins KR, Dhara SK, West FD, Stice SL.

Tissue Eng Part A. 2009 Aug;15(8):1897-907. doi: 10.1089/ten.tea.2008.0351.

19.

Skeletal muscle-derived stem cells: implications for cell-mediated therapies.

Usas A, Mačiulaitis J, Mačiulaitis R, Jakubonienė N, Milašius A, Huard J.

Medicina (Kaunas). 2011;47(9):469-79. Epub 2011 Dec 2. Review.

20.

Human Cartilage-Derived Progenitor Cells From Committed Chondrocytes for Efficient Cartilage Repair and Regeneration.

Jiang Y, Cai Y, Zhang W, Yin Z, Hu C, Tong T, Lu P, Zhang S, Neculai D, Tuan RS, Ouyang HW.

Stem Cells Transl Med. 2016 Jun;5(6):733-44. doi: 10.5966/sctm.2015-0192. Epub 2016 Apr 29.

Supplemental Content

Support Center